SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from PALISADE BIO, INC. (PALI) (CIK 0001357459) (PALI) — Aug 29, 2006

PALISADE BIO, INC. (PALI) (CIK 0001357459)
Date: Aug. 29, 2006 · CIK: 0001357459 · Accession: 0001144204-06-036236

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-132923

Date
Aug. 29, 2006
Author
Chief
Form
CORRESP
Company
PALISADE BIO, INC. (PALI) (CIK 0001357459)

Letter

VIA EDGAR United States Securities and Exchange Commission RE: NEURALSTEM, INC. REGISTRATION STATEMENT ON FORM SB-2 FILE NUMBER 333-132923

Dear Ms. Barros:

Based upon the conversation between Mr. Mark Brunhofer of the Commission and our attorneys on August 29, 2006, in which Mr. Brunhofer notified our attorneys that the foregoing registration statement was cleared for effectiveness, please be advised that Neuralstem, Inc. hereby requests that the registration statement be declared effective no later than by the close of business as of Friday, September 1, 2006.

We hereby acknowledge that:

1.

Should the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, such action will not foreclose the Commission from taking any action with respect to the filing.

2.

The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, will not relieve Neuralstem, Inc. from its full responsibility for the adequacy and accuracy of the disclosure in the filing.

3.

Neuralstem, Inc. may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Very
truly
yours,
/s/
Richard
Garr

Show Raw Text
CORRESP
1
filename1.htm

    NEURALSTEM,
      INC.

    9700
      GREAT SENECA HIGHWAY, SUITE 240

    ROCKVILLE,
      MD 20850

    (301)
      366-4841

    August
      29, 2006

    VIA
      EDGAR

    Sonia
      Barros

    United
      States Securities and Exchange Commission

    100
      F
      Street, NE

    Washington
      D.C. 20549

            RE:

              NEURALSTEM,
                INC.

              REGISTRATION
                STATEMENT ON FORM SB-2

              FILE
                NUMBER 333-132923

    Dear
      Ms.
      Barros:

    Based
      upon the conversation between Mr. Mark
      Brunhofer
      of the
      Commission and our attorneys on August 29, 2006, in which Mr. Brunhofer notified
      our attorneys that the foregoing registration statement was cleared for
      effectiveness, please be advised that Neuralstem, Inc. hereby requests that
      the
      registration statement be declared effective no later than by the close of
      business as of Friday, September 1, 2006.

    We
      hereby
      acknowledge that:

            1.

              Should
                the Commission or the staff, acting pursuant to delegated authority,
                in
                declaring the filing effective, such action will not foreclose the
                Commission from taking any action with respect to the
                filing.

            2.

              The
                action of the Commission or the staff, acting pursuant to delegated
                authority, in declaring the filing effective, will not relieve Neuralstem,
                Inc. from its full responsibility for the adequacy and accuracy of
                the
                disclosure in the filing.

            3.

              Neuralstem,
                Inc. may not assert staff comments and the declaration of effectiveness
                as
                a defense in any proceeding initiated by the Commission or any person
                under the federal securities laws of the United
                States.

                Very
      truly
      yours,

                /s/
      Richard
      Garr

                Richard
      Garr

                Chief
      Executive
      Officer